Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
13.81
-1.38 (-9.08%)
Dec 3, 2024, 12:14 PM EST - Market open
Cadrenal Therapeutics Employees
Cadrenal Therapeutics had 4 employees as of December 31, 2023. The number of employees increased by 1 or 33.33% compared to the previous year.
Employees
4
Change (1Y)
1
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,902,040
Market Cap
24.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | 1 | 33.33% |
| Dec 31, 2022 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| DarioHealth | 294 |
| BioLineRx | 79 |
| IGC Pharma | 67 |
| DURECT | 58 |
| VSee Health | 40 |
| IN8bio | 31 |
| NeurAxis | 19 |
| CERo Therapeutics Holdings | 9 |
CVKD News
- 14 days ago - Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook - PRNewsWire
- 21 days ago - CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS - PRNewsWire
- 26 days ago - CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE - PRNewsWire
- 4 weeks ago - Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds - PRNewsWire
- 5 weeks ago - Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility - PRNewsWire
- 5 weeks ago - CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM - PRNewsWire
- 2 months ago - Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference - PRNewsWire
- 3 months ago - Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients - PRNewsWire